TNFRSF8 Antikörper (FITC)

Produktnummer ABIN536664

Produktdetails anti-TNFRSF8 Antikörper (FITC)

Target: TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser TNFRSF8 Antikörper ist konjugiert mit FITC

Applikation: Flow Cytometry (FACS)

Verwendungszweck: Mouse monoclonal antibody raised against TNFRSF8.

Spezifität: This antibody recognizes extracellular part of CD30 (Ki-1 antigen), a 105 KDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells.

Kreuzreaktivität: Human

Immunogen: Expression vector containing CD30 cDNA (booster suspension of THP-1 cell line).

Klon: MEM-268

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Flow Cytometry (20 µL in human blood cells 100 µL in whole blood or 10⁶ cells in a suspension)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.2 % BSA, 0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store in the dark at 4°C. Do not freeze.
Avoid prolonged exposure to light.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-TNFRSF8 Antikörper (FITC) (ABIN536664)

Kusanovic, Romero, Hassan, Gotsch, Edwin, Chaiworapongsa, Erez, Mittal, Mazaki-Tovi, Soto, Than, Friel, Yoon, Espinoza: "Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies." in: The journal of maternal-fetal & neonatal medicine, Vol. 20, Issue 12, pp. 867-78, (2008) (PubMed).

Wright, Rumble, Duckett: "CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells." in: The Journal of biological chemistry, Vol. 282, Issue 14, pp. 10252-62, (2007) (PubMed).

Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: "Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease." in: Blood, Vol. 109, Issue 5, pp. 2225-33, (2007) (PubMed).

Details zu TNFRSF8

Target: TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))

Andere Bezeichnung: CD30 (TNFRSF8 Produkte)

Synonyme: CD30 antikoerper, D1S166E antikoerper, Ki-1 antikoerper, Cd30 antikoerper, Ki antikoerper, TNFRSF8 antikoerper, TNF receptor superfamily member 8 antikoerper, tumor necrosis factor receptor superfamily, member 8 antikoerper, TNFRSF8 antikoerper, Tnfrsf8 antikoerper

Gen-ID: 943